Issue 1, 2023
From the journal:

Biomaterials Science

Correction: Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics

Xinxin Liu,a   Zhongwen Yuan,a   Zheng Tang,a   Qi Chen,a   Jiarun Huang,a   Lizhen He*ab  and  Tianfeng Chen*ab  

* Corresponding authors

a Department of Neurology and Stroke Center of The First Affiliated Hospital, and Department of Chemistry, Jinan University, Guangzhou 510632, China
E-mail: hlz6371@jnu.edu.cn, tchentf@jnu.edu.cn

b The Guangzhou Key Laboratory of Molecular and Functional Imaging for Clinical Translation, Guangzhou 510632, China

Abstract

Correction for ‘Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics’ by Xinxin Liu et al., Biomater. Sci., 2021, 9, 4691–4700, https://doi.org/10.1039/d1bm00348h.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D2BM90091B
Article type
Correction
Submitted
24 Nov 2022
Accepted
24 Nov 2022
First published
29 Nov 2022
This article is Open Access
Creative Commons BY license

Biomater. Sci., 2023,11, 339-340

Permissions

Request permissions

Correction: Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics

X. Liu, Z. Yuan, Z. Tang, Q. Chen, J. Huang, L. He and T. Chen, Biomater. Sci., 2023, 11, 339 DOI: 10.1039/D2BM90091B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements